Your browser doesn't support javascript.
loading
Tanshinone I exerts cardiovascular protective effects in vivo and in vitro through inhibiting necroptosis via Akt/Nrf2 signaling pathway.
Zhuo, Youqiong; Yuan, Renyikun; Chen, Xinxin; He, Jia; Chen, Yangling; Zhang, Chenwei; Sun, Kaili; Yang, Shilin; Liu, Zhenjie; Gao, Hongwei.
Afiliação
  • Zhuo Y; College of Pharmacy, Guangxi University of Chinese Medicine, Nanning, 530000, China.
  • Yuan R; Guangxi Engineering Technology Research Center of Advantage Chinese Patent Drug and Ethnic Drug Development, Nanning, 530200, China.
  • Chen X; State Key Laboratory of Innovative Drug and Efficient Energy-Saving Pharmaceutical Equipment, Jiangxi University of Traditional Chinese Medicine, Nanchang, 330004, China.
  • He J; College of Pharmacy, Guangxi University of Chinese Medicine, Nanning, 530000, China.
  • Chen Y; Guangxi Engineering Technology Research Center of Advantage Chinese Patent Drug and Ethnic Drug Development, Nanning, 530200, China.
  • Zhang C; College of Pharmacy, Guangxi University of Chinese Medicine, Nanning, 530000, China.
  • Sun K; Guangxi Engineering Technology Research Center of Advantage Chinese Patent Drug and Ethnic Drug Development, Nanning, 530200, China.
  • Yang S; College of Pharmacy, Guangxi University of Chinese Medicine, Nanning, 530000, China.
  • Liu Z; Guangxi Engineering Technology Research Center of Advantage Chinese Patent Drug and Ethnic Drug Development, Nanning, 530200, China.
  • Gao H; College of Pharmacy, Guangxi University of Chinese Medicine, Nanning, 530000, China.
Chin Med ; 16(1): 48, 2021 Jun 28.
Article em En | MEDLINE | ID: mdl-34183021

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Chin Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Chin Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China